These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 15995007

  • 1. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients.
    American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 2005 Aug; 116(2):496-505. PubMed ID: 15995007
    [Abstract] [Full Text] [Related]

  • 2. Prevention of meningococcal disease.
    Kimmel SR.
    Am Fam Physician; 2005 Nov 15; 72(10):2049-56. PubMed ID: 16342836
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Oct 14; 54(40):1023-5. PubMed ID: 16224452
    [Abstract] [Full Text] [Related]

  • 7. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines.
    Poland GA.
    Clin Infect Dis; 2010 Mar 01; 50 Suppl 2():S45-53. PubMed ID: 20144016
    [Abstract] [Full Text] [Related]

  • 8. Optimizing protection against meningococcal disease.
    Reisinger KS, Black S, Stoddard JJ.
    Clin Pediatr (Phila); 2010 Jun 01; 49(6):586-97. PubMed ID: 20089551
    [Abstract] [Full Text] [Related]

  • 9. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Aug 05; 60(30):1018-9. PubMed ID: 21814165
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 25; 58(37):1042-3. PubMed ID: 19779400
    [Abstract] [Full Text] [Related]

  • 12. Update on prevention of meningococcal disease: focus on tetravalent meningococcal conjugate vaccine.
    Mehlhorn AJ, Balcer HE, Sucher BJ.
    Ann Pharmacother; 2006 Apr 25; 40(4):666-73. PubMed ID: 16595570
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC).
    MMWR Recomm Rep; 2005 May 27; 54(RR-7):1-21. PubMed ID: 15917737
    [Abstract] [Full Text] [Related]

  • 15. Menactra: a meningococcal conjugate vaccine.
    Med Lett Drugs Ther; 2005 Apr 11; 47(1206):29-31. PubMed ID: 15821633
    [Abstract] [Full Text] [Related]

  • 16. Meningococcal conjugate vaccines policy update: booster dose recommendations.
    Committee on Infectious Diseases.
    Pediatrics; 2011 Dec 11; 128(6):1213-8. PubMed ID: 22123893
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May 11; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 18. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group.
    Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428
    [Abstract] [Full Text] [Related]

  • 19. Meningococcal conjugate vaccine uptake, measured by Michigan's immunization registry.
    Enger KS, Stokley S.
    J Adolesc Health; 2007 May 01; 40(5):398-404. PubMed ID: 17448396
    [Abstract] [Full Text] [Related]

  • 20. MenACWY-CRM, a novel quadrivalent glycoconjugate vaccine against Neisseria meningitidis for the prevention of meningococcal infection.
    Pace D.
    Curr Opin Mol Ther; 2009 Dec 01; 11(6):692-706. PubMed ID: 20072946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.